PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32254955-8	2019	Under combination therapy, Pd-Cys@MTX@RGD was shown to effectively inhibit the inflammatory response induced by vascular endothelial growth factor (VEGF) and IL-1beta.	pd-cys	27-33	vascular endothelial growth factor A	Homo sapiens	112-146
32254955-8	2019	Under combination therapy, Pd-Cys@MTX@RGD was shown to effectively inhibit the inflammatory response induced by vascular endothelial growth factor (VEGF) and IL-1beta.	pd-cys	27-33	vascular endothelial growth factor A	Homo sapiens	148-152
32254955-8	2019	Under combination therapy, Pd-Cys@MTX@RGD was shown to effectively inhibit the inflammatory response induced by vascular endothelial growth factor (VEGF) and IL-1beta.	pd-cys	27-33	interleukin 1 alpha	Homo sapiens	158-166
32254955-9	2019	And, in vivo, multifunctional Pd-Cys@MTX@RGD effectively inhibited the symptoms of RA by inhibiting the expression of pro-inflammatory cytokines (TNF-alpha,COX-2).	pd-cys	30-36	tumor necrosis factor	Homo sapiens	146-155
32254955-9	2019	And, in vivo, multifunctional Pd-Cys@MTX@RGD effectively inhibited the symptoms of RA by inhibiting the expression of pro-inflammatory cytokines (TNF-alpha,COX-2).	pd-cys	30-36	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	156-161